Patents by Inventor Eamonn P. Hobbs

Eamonn P. Hobbs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240102993
    Abstract: A method for optimal selection of cytotoxic agents for organ or region specific therapy that includes extracorporeal filtration of the cytotoxic agent from blood drained from the organ or region being treated and return of the filtered blood to a mammal is disclosed.
    Type: Application
    Filed: November 29, 2023
    Publication date: March 28, 2024
    Applicant: Delcath Systems, Inc.
    Inventors: Eamonn P. Hobbs, Daniel S. Johnston
  • Patent number: 11867686
    Abstract: A method for optimal selection of cytotoxic agents for organ or region specific therapy that includes extracorporeal filtration of the cytotoxic agent from blood drained from the organ or region being treated and return of the filtered blood to a mammal is disclosed.
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: January 9, 2024
    Assignee: Delcath Systems, Inc.
    Inventors: Eamonn P. Hobbs, Daniel S. Johnston
  • Publication number: 20230404642
    Abstract: The present disclosure provides, among other things, methods of cancer treatment comprising steps of: a) intratumoral cell lysis, mediated by cryolysis; and b) intratumoral administration of 1) a combination of immunotherapeutic agents comprising: i) a TLR9 agonist CpG oligodeoxydinucleotide, ii) an agonistic anti-CD40 monoclonal antibody, iii) an agonistic anti-OX40 monoclonal antibody and iv) an anti-CTLA4 monoclonal antibody; or 2) a combination of immunotherapeutic agents comprising: i) a TLR9 agonist CpG oligodeoxydinucleotide, ii) an agonistic anti-CD40 monoclonal antibody, iii) an anti-PD1 monoclonal antibody and iv) an anti-CTLA4 monoclonal antibody.
    Type: Application
    Filed: June 1, 2023
    Publication date: December 21, 2023
    Inventors: Charles J. Link, JR., Jason R. Williams, Mario R. Mautino, Daniel K. Recinelia, Eamonn P. Hobbs
  • Publication number: 20200300839
    Abstract: A method for optimal selection of cytotoxic agents for organ or region specific therapy that includes extracorporeal filtration of the cytotoxic agent from blood drained from the organ or region being treated and return of the filtered blood to a mammal is disclosed.
    Type: Application
    Filed: June 4, 2020
    Publication date: September 24, 2020
    Applicant: Delcath Systems, Inc.
    Inventors: Eamonn P. Hobbs, Daniel S. Johnston
  • Patent number: 9782562
    Abstract: A method of treating varicose veins and other vascular diseases provides sclerosant fluid through a catheter into the body vessel to be treated. The catheter has a lumen and a plurality of sidewall exits. The sclerosant fluid is provided under sufficient pressure so that it comes out of each exit as a jet of fluid with sufficient velocity to impinge on the vessel wall substantially orthogonal to the wall and thus minimize dilution of the sclerosant fluid and optimize coverage. A movable sheath on the catheter permits selecting a portion of the exits to be uncovered and thus create an infusion zone for the jets of sclerosant fluid which approximately match a desired treatment zone.
    Type: Grant
    Filed: January 6, 2016
    Date of Patent: October 10, 2017
    Inventors: Eamonn P Hobbs, William M Appling
  • Publication number: 20170106167
    Abstract: The method of treating varicose veins and other vascular diseases provides sclerosant fluid through a catheter into the body vessel to be treated. The catheter has a lumen and a plurality of sidewall exits. The sclerosant fluid is provided under sufficient pressure so that it comes out of each exit as a jet of fluid with sufficient velocity to impinge on the vessel wall substantially orthogonal to the wall and thus minimize dilution of the sclerosant fluid and optimize coverage. A movable sheath on the catheter permits selecting a portion of the exits to be uncovered and thus create an infusion zone for the jets of sclerosant fluid which approximately match a desired treatment zone.
    Type: Application
    Filed: September 20, 2016
    Publication date: April 20, 2017
    Applicant: AngioDynamics, Inc.
    Inventors: Eamonn P Hobbs, William M Appling
  • Patent number: 9541544
    Abstract: A method for optimal selection of cytotoxic agents for organ or region specific therapy that includes extracorporeal filtration of the cytotoxic agent from blood drained from the organ or region being treated and return of the filtered blood to a mammal is disclosed.
    Type: Grant
    Filed: August 28, 2013
    Date of Patent: January 10, 2017
    Assignee: Delcath Systems, Inc.
    Inventors: Eamonn P. Hobbs, Daniel S. Johnston
  • Publication number: 20160192944
    Abstract: The method of treating varicose veins and other vascular diseases provides sclerosant fluid through a catheter into the body vessel to be treated. The catheter has a lumen and a plurality of sidewall exits. The sclerosant fluid is provided under sufficient pressure so that it comes out of each exit as a jet of fluid with sufficient velocity to impinge on the vessel wall substantially orthogonal to the wall and thus minimize dilution of the sclerosant fluid and optimize coverage. A movable sheath on the catheter permits selecting a portion of the exits to be uncovered and thus create an infusion zone for the jets of sclerosant fluid which approximately match a desired treatment zone.
    Type: Application
    Filed: January 6, 2016
    Publication date: July 7, 2016
    Applicant: AngioDynamics, Inc.
    Inventors: Eamonn P Hobbs, William M Appling
  • Patent number: 9173704
    Abstract: An indwelling venous catheter and method capable of destroying undesirable cellular growth is provided. The catheter includes a shaft having at least one lumen and adapted to be placed inside a vein for long term use. A plurality of electrodes are positioned near a distal section of the shaft and are adapted to receive from a voltage generator a plurality of electrical pulses in an amount sufficient to cause destruction of cells in the undesirable cellular growth that have grown around the shaft. In one aspect of the invention, a probe is configured to be removably insertable into the at least one lumen and the electrodes are positioned near the distal section of the probe.
    Type: Grant
    Filed: June 19, 2009
    Date of Patent: November 3, 2015
    Assignee: AngioDynamics, Inc.
    Inventors: Eamonn P. Hobbs, William C. Hamilton, Jr.
  • Patent number: 8562588
    Abstract: A method and device are herein described to treat a target region of tissue, using at least one energy delivery device coupled to a power source and positioned in a treatment position so as to irreversibly electroporate tissue to ablate a target region, and introduce regenerative materials into a treated region.
    Type: Grant
    Filed: July 24, 2012
    Date of Patent: October 22, 2013
    Assignee: AngioDynamics, Inc.
    Inventors: Eamonn P. Hobbs, James G. Lovewell, Robert M. Pearson
  • Publication number: 20120289888
    Abstract: A method and device are herein described to treat a target region of tissue, using at least one energy delivery device coupled to a power source and positioned in a treatment position so as to irreversibly electroporate tissue to ablate a target region, and introduce regenerative materials into a treated region.
    Type: Application
    Filed: July 24, 2012
    Publication date: November 15, 2012
    Inventors: Eamonn P. Hobbs, James G. Lovewell, Robert M. Pearson
  • Patent number: 8231603
    Abstract: A method and device are herein described to treat a target region of tissue, using at least one energy delivery device coupled to a power source and positioned in a treatment position so as to irreversibly electroporate tissue to ablate a target region, and introduce regenerative materials into a treated region.
    Type: Grant
    Filed: February 10, 2010
    Date of Patent: July 31, 2012
    Assignee: AngioDynamics, Inc.
    Inventors: Eamonn P. Hobbs, James G. Lovewell, Robert M. Pearson
  • Patent number: 8057460
    Abstract: A multiple tube catheter, such as a hemo-dialysis catheter, has first and second tubes which are attached to each other over a zone by one or more longitudinally extending wires which joins the two tubes over that zone. When a catheter is implanted in the patient, the attached zone is within the patient so that the catheter cannot be removed or advanced. When the catheter is to be removed, the longitudinally extending wire or wires are pulled proximally out of the tubes involved so that the two tubes can be separated and individually removed. A flexible separating prong within the patient and proximal of the zone holds the tubes apart to further assure that the catheter cannot be moved.
    Type: Grant
    Filed: October 22, 2007
    Date of Patent: November 15, 2011
    Assignee: AngioDynamics, Inc
    Inventors: Eamonn P. Hobbs, William M. Appling, Angelo J. Tarricone, Theodore J. Beyer
  • Publication number: 20100204638
    Abstract: A method and device are herein described to treat a target region of tissue, using at least one energy delivery device coupled to a power source and positioned in a treatment position so as to irreversibly electroporate tissue to ablate a target region, and introduce regenerative materials into a treated region.
    Type: Application
    Filed: February 10, 2010
    Publication date: August 12, 2010
    Applicant: ANGIODYNAMICS, INC.
    Inventors: Eamonn P. Hobbs, James G. Lovewell, Robert M. Pearson
  • Publication number: 20100152725
    Abstract: A system for selectively ablating tissue is provided herein that has at least one energy source that has a non-thermal energy source and a thermal energy source, at least one probe, means for selectively coupling the probe to one desired energy source of the at least one energy source, means for selectively energizing the non-thermal energy source of the at least one energy source to apply non-thermal energy to at least a portion of the desired region to ablate at least a portion of the desired region, and means for selectively energizing the thermal energy source of the at least one energy source during the withdrawal of the at least one probe to thermally ablate tissue substantially adjacent to a probe track.
    Type: Application
    Filed: November 30, 2009
    Publication date: June 17, 2010
    Applicant: AngioDynamics, Inc.
    Inventors: Robert M. Pearson, Eamonn P. Hobbs, William M. Appling
  • Publication number: 20090318849
    Abstract: An indwelling venous catheter and method capable of destroying undesirable cellular growth is provided. The catheter includes a shaft having at least one lumen and adapted to be placed inside a vein for long term use. A plurality of electrodes are positioned near a distal section of the shaft and are adapted to receive from a voltage generator a plurality of electrical pulses in an amount sufficient to cause destruction of cells in the undesirable cellular growth that have grown around the shaft. In one aspect of the invention, a probe is configured to be removably insertable into the at least one lumen and the electrodes are positioned near the distal section of the probe.
    Type: Application
    Filed: June 19, 2009
    Publication date: December 24, 2009
    Inventors: Eamonn P. Hobbs, William C. Hamilton, JR.
  • Publication number: 20080208236
    Abstract: A dermal marking and a method of identifying the characteristics of an implanted medical device using the dermal marking. The method involves providing an implantable medical device, implanting a medical device in a patient, providing at least one dermal marking that contains information disclosing at least one characteristic of the implanted medical device, applying the at least one dermal marking to the skin of the patient, perceiving the dermal marking on the patient's skin, and identifying at least one characteristic of the implantable medical device based on the dermal marking.
    Type: Application
    Filed: February 28, 2008
    Publication date: August 28, 2008
    Applicant: AngioDynamics, Inc.
    Inventors: Eamonn P. Hobbs, William M. Appling
  • Patent number: 7347852
    Abstract: A multiple tube catheter, such as a hemo-dialysis catheter, has first and second tubes which are attached to each other over a zone by one or more longitudinally extending wires which joins the two tubes over that zone. When a catheter is implanted in the patient, the attached zone is within the patient so that the catheter cannot be removed or advanced. When the catheter is to be removed, the longitudinally extending wire or wires are pulled proximally out of the tubes involved so that the two tubes can be separated and individually removed. A flexible separating prong within the patient and proximal of the zone holds the tubes apart to further assure that the catheter cannot be moved.
    Type: Grant
    Filed: November 20, 2001
    Date of Patent: March 25, 2008
    Assignee: AngioDynamics, Inc.
    Inventors: Eamonn P. Hobbs, William M. Appling, Angelo J. Tarricone, Theodore J. Beyer
  • Publication number: 20030097091
    Abstract: A multiple tube catheter, such as a hemo-dialysis catheter, has first and second tubes which are attached to each other over a zone by one or more longitudinally extending wires which joins the two tubes over that zone. When a catheter is implanted in the patient, the attached zone is within the patient so that the catheter cannot be removed or advanced. When the catheter is to be removed, the longitudinally extending wire or wires are pulled proximally out of the tubes involved so that the two tubes can be separated and individually removed. A flexible separating prong within the patient and proximal of the zone holds the tubes apart to further assure that the catheter cannot be moved.
    Type: Application
    Filed: November 20, 2001
    Publication date: May 22, 2003
    Inventors: Eamonn P. Hobbs, William M. Appling, Angelo J. Tarricone, Theodore J. Beyer
  • Patent number: 5439449
    Abstract: A needle system which upon arterial entry provides a visual indication of pulsatile blood flow. The needle system includes an elongated needle with distal and proximal ends. There is a needle hub at the proximal end of the needle and a port position between the proximal needle end and proximal hub end. The visualization connector tube having two ends is provided. The tube is sufficiently clear to permit visualization of material held therein. The first end of the tube is in communication with the port. An elastomeric reservoir is provided. The reservoir is in free, direct, unrestricted two-way communication with a second tube end. The needle, needle hub, and tube all have predetermined volumes. The reservoir has an initial unexpanded state with a first pressure and a first volume and a second state expanded with a second pressure and a second volume. Air pressure in the needle system is increased upon arterial entry.
    Type: Grant
    Filed: April 22, 1994
    Date of Patent: August 8, 1995
    Assignee: E-Z-Em, Inc.
    Inventors: Harold C. Mapes, William M. Appling, Michael P. Cody, Eamonn P. Hobbs